404
+1-313-307-4176
sales@stratviewresearch.com
Automated Breast Ultrasound Systems Market Report
Automated Breast Ultrasound Systems Market, By Product (Automated Breast Ultrasound System (ABUS), Automated Breast Volume Scanner (ABVS)), Application (Hospitals and Diagnostic Centers, Clinics, Ambulatory Surgical Centers), and Region - COVID-1...
Impact of COVID-19 on Automated Breast Ultrasound Systems Market
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Automated Breast Ultrasound Systems market is projected to grow from USD 591.3 million in 2020 to USD 1431.0 million by 2026 at a CAGR of around 16.1% during the forecast period.
Wish to get a free sample? Register Here
Automated breast ultrasound (ABUS) is a breast cancer screening technology used for the detection of dense breast tissue in women. This technology is used as an adjunct to mammography for screening breast cancers in asymptomatic women with dense breasts. Based on the product, it can be categorized as an automated breast ultrasound system (ABUS) and automated breast volume scanner (ABVS).
Key players operating in the Automated Breast Ultrasound Systems market are-
The growth of the global automated breast ultrasound systems market is primarily driven by the rising number of women suffering from breast cancer. Cancer is the second leading cause of death worldwide and breast cancer is one of the most commonly occurring cancers in women. Growing inclination toward a sedentary lifestyle has also resulted in the rising number of cancer patients. In addition to this, the rising demand for advanced technologies for cancer detection and diagnosis is likely to create lucrative opportunities for the players operating in the global market in the coming years.
By application, the automated breast ultrasound systems market has been bifurcated into hospitals and diagnostic centers, clinics, and ambulatory surgical centers. Under these, the hospitals and diagnostic centers segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to the presence of required infrastructure and skilled staff in hospitals.
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The regional growth can be attributed to the high adoption rate of advanced technologies in the healthcare industry coupled with the presence of key market players such as GE Healthcare (US) and SonoCiné Inc. (US). The market growth in the Asia-Pacific region is expected to be driven by the rising number of people suffering from cancer.
The covid-19 outbreak posed significant challenges across verticals worldwide. It impacted the growth of the automated breast ultrasound systems market negatively as the imposition of complete lockdown and restrictions on trade resulted in a decline in visits to hospitals.
Here is the list of the group of customers that the automated breast ultrasound systems market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.
The automated breast ultrasound systems market is expected to witness an impressive growth of 16.1% CAGR in the coming years.
GE Healthcare (US), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), SonoCiné Inc. (US), Qview Medical (US), Seno Medical Instruments (US), Volpara Solutions Limited (New Zealand), Delphinus Medical Technologies, Inc. (US), CapeRay (South Af-rica), SuperSonic Imagine, Inc. (France), Nova Medical Inc (US), Theraclion (France), Metritrack Inc (US) and Toshiba Corporation (Japan) are among the key players in the automated breast ultrasound systems market.
The automated breast ultrasound systems market size is expected to reach USD 1431.0 million in the foreseeable future.
The hospitals and diagnostic centers segment is expected to register significant growth in the automate breast ultrasound systems market in the coming years.
North America accounted for the largest share in the automated breast ultrasound systems market in 2020.
Automated breast ultrasound systems distributors, Automated breast ultrasound systems suppliers, Automated breast ultrasound systems manufacturers, Logistics organizations, Government bodies are the target audience in the automated breast ultrasound systems market.
WE ACCEPT
